Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07294482 · ClinicalTrials.gov registry record · NA

The Effects on Sleep Quality of 1:4 Reishi Liquid Extract

A NA study of Sleep, sponsored by Efforia.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT07294482 is a NA study of Sleep that is actively recruiting participants, run by Efforia. The registered enrollment target is 100 participants, below the 4,165-participant average among 151 other Sleep trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07294482, a NA study of Sleep, is actively recruiting participants, sponsored by Efforia.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

Examining the effects of 1ml of Reishi mushroom extract (1:4 extraction ratio, two hot water extractions and an alcohol extraction), taken daily, 30 mins before bed on perceived sleep quality and stress levels. Sleep quality includes: duration, sleep onset latency, nighttime wakings, and perceived restfulness. And consequently, the potential for increased daytime energy levels and a reduction in perceived stress levels.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Bristol Fungarium's 1:4 Reishi Mushroom Tincture

Study Locations (1)

New York

  • Efforia - New York

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2025-09-10
Est. Completion 2026-09-10
Phase NA

Sponsor

Efforia

19 total trials

What the Registry Record Tells You About NCT07294482

The ClinicalTrials.gov registry entry for NCT07294482 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,165-participant average among 151 other Sleep trials with a reported enrollment target (98% lower). The listed sponsor is Efforia, which has 19 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Sleep appearing as the primary indexed condition, and to 1 intervention - of which Bristol Fungarium's 1:4 Reishi Mushroom Tincture is the first listed.

NCT07294482 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT07294482 about?

NCT07294482 is a clinical study titled "The Effects on Sleep Quality of 1:4 Reishi Liquid Extract". Examining the effects of 1ml of Reishi mushroom extract (1:4 extraction ratio, two hot water extractions and an alcohol extraction), taken daily, 30 mins before bed on perceived sleep quality and stress levels. Sleep quality includes: duration, sleep onset latency, nighttime wakings, and perceived r...

What is the current status of trial NCT07294482?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-09-10. Estimated completion is 2026-09-10.

What conditions does trial NCT07294482 study?

This clinical trial studies the following conditions: Sleep.

What interventions are being tested in trial NCT07294482?

The interventions under investigation include: Bristol Fungarium's 1:4 Reishi Mushroom Tincture (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT07294482?

This trial is sponsored by Efforia, which has 19 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07294482 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sleep

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.